Longest Follow-Up for ICI Plus TKI Favours Treatment with Avelumab Plus Axitinib Combination versus Sunitinib in Patients with Advanced RCC By Ogkologos - February 11, 2025 682 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a final analysis of the JAVELIN Renal 101 study Source RELATED ARTICLESMORE FROM AUTHOR The Legacy of the ESMO Patient Engagement Summit 2025: Advancing Rights of Patients with Cancer via Cross-Border Best Practices and Collaboration Sustained PFS Benefit of Imlunestrant Over SoC in Patients with ESR1-mutated Advanced Breast Cancer ESMO Welcomes Launch of Health Package Introducing EU Measures That Can Boost Innovation in Oncology and Help Prevent New Cancer Cases MOST POPULAR Can mRNA Vaccines Help Treat Cancer? January 20, 2022 Pyrotinib in HER2-mutated Advanced NSCLC Previously Treated with Chemotherapy July 13, 2020 Mom Walks In To Comfort Scared Son After Surgery And Sees... June 26, 2019 Cervical screening in Wales extended to every 5 years: Why the... January 7, 2022 Load more HOT NEWS ctDNA Analysis is Feasible for Detection of Minimal Residual Disease After... Adding Epcoritamab to Lenalidomide and Rituximab Results in Higher Response Rate... Tipifarnib Demonstrates Encouraging Efficacy in Patients with Recurrent and/or Metastatic HNSCC... Techniques for Successful Glucose Daddies and Babies Relationships
